Loading insider details...
Beta
Latest Form 4 (Sep 4, 2026): Grant/Award of 112,000 PLX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 112,000 | n/a |
| Sep 4, 2025 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 25,000 | n/a |
| Sep 24, 2024 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 100,000 | n/a |
| Aug 17, 2023 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 187,344 | n/a |
| Sep 9, 2022 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 340,000 | n/a |
| Aug 13, 2020 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 122,656 | n/a |